Targeting TGFb Pathway Dependencies in Group 3 Medulloblastoma |
University of California San Francisco / Zulekha Qadeer, PhD |
Young Investigator Grants |
2019 |
California |
Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries |
University of Utah / Anne Kirchhoff, PhD/MPH |
Epidemiology Grants |
2019 |
Utah |
Profiling the Transcriptional Heterogeneity of Diverse Pediatric Solid Tumors |
St. Jude Children’s Research Hospital / Michael Dyer, PhD and Xiang Chen, PhD |
Single-cell Pediatric Cancer Atlas Grant |
2019 |
Tennessee |
The Impact Of CD56neg NK Cells in the Pathogenesis of Endemic Burkitt Lymphoma |
University of Massachusetts Medical School / Catherine Forconi, PhD |
Young Investigator Grants |
2019 |
Massachusetts |
Dissecting Microenvironmental Interactions in Pediatric High-Grade Gliomas that Promote Tumor Growth |
Dana-Farber Cancer Institute / Mariella G. Filbin, MD/PhD |
Crazy 8 Pilots |
2019 |
Massachusetts |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma |
The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD |
'A' Award Grants |
2019 |
California |
Characterization of Chromatin Landscapes to Identify Therapeutic Vulnerabilities in Diffuse Midline Gliomas. |
Fred Hutchinson Cancer Research Center / Jay Sarthy, MD/PhD |
Young Investigator Grants |
2019 |
Washington |
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |
Live-Cell Surface Proteomic Characterization of Atypical Teratoid Rhabdoid Tumors Using High Throughout Multi-Color Flow |
University of Colorado Denver / Siddhartha S. Mitra, PhD |
Crazy 8 Pilots |
2019 |
Colorado |
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida / Catherine Flores, PhD |
Innovation Grants |
2019 |
Florida |